1. Home
  2. RM vs TECX Comparison

RM vs TECX Comparison

Compare RM & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regional Management Corp.

RM

Regional Management Corp.

HOLD

Current Price

$36.47

Market Cap

356.4M

Sector

Finance

ML Signal

HOLD

Logo Tectonic Therapeutic Inc. Common Stock

TECX

Tectonic Therapeutic Inc. Common Stock

HOLD

Current Price

$20.16

Market Cap

359.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
RM
TECX
Founded
1987
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
356.4M
359.0M
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
RM
TECX
Price
$36.47
$20.16
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$30.00
$81.20
AVG Volume (30 Days)
54.3K
363.4K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
3.27%
N/A
EPS Growth
71.26
N/A
EPS
4.13
N/A
Revenue
$610,145,000.00
N/A
Revenue This Year
$16.34
N/A
Revenue Next Year
$7.05
N/A
P/E Ratio
$8.88
N/A
Revenue Growth
9.60
N/A
52 Week Low
$25.41
$13.70
52 Week High
$46.00
$61.07

Technical Indicators

Market Signals
Indicator
RM
TECX
Relative Strength Index (RSI) 42.44 54.59
Support Level $36.84 $18.60
Resistance Level $37.73 $21.50
Average True Range (ATR) 1.32 1.68
MACD 0.03 0.04
Stochastic Oscillator 23.58 57.51

Price Performance

Historical Comparison
RM
TECX

About RM Regional Management Corp.

Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: